Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.
V. Bonnefoy (Créteil, France), L. Boyer (Créteil, France), E. Audureau (Créteil, France), L. Bassinet (Créteil, France), S. Zebachi (Créteil, France), B. Douvry (Créteil, France), I. Monnet (Créteil, France), G. Mangiapan (Créteil, France), A. Boudjemaa (Créteil, France), C. Touboul (Créteil, France), L. Ernande (Créteil, France), B. Housset (Créteil, France), B. Maitre (Créteil, France), F. Schlemmer (Créteil, France)
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Bonnefoy (Créteil, France), L. Boyer (Créteil, France), E. Audureau (Créteil, France), L. Bassinet (Créteil, France), S. Zebachi (Créteil, France), B. Douvry (Créteil, France), I. Monnet (Créteil, France), G. Mangiapan (Créteil, France), A. Boudjemaa (Créteil, France), C. Touboul (Créteil, France), L. Ernande (Créteil, France), B. Housset (Créteil, France), B. Maitre (Créteil, France), F. Schlemmer (Créteil, France). Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.. 2724
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: